aod9604 supplementation intent purpose AOD 9604 Peptide Guide: Dosing,
Description
[DOI] [PubMed] [Google Scholar] 174.Adams AC, Clapham JC, Wynick D, Speakman JR

For use as an aid in the management of vitamin B12 deficiencies in horses, dogs, and cats

Q: How long does it take to see results

Research trials often employ a once-weekly subcutaneous micro-dosing approach, typically around 0.1 mL, to maintain consistent exposure levels in peptide models

It remains an investigational peptide, not an approved pharmaceutical